Tom 13, Nr 4 (2018)
UCZYMY SIĘ!
Opublikowany online: 2018-09-11

dostęp otwarty

Wyświetlenia strony 2449
Wyświetlenia/pobrania artykułu 22328
Pobierz cytowanie

Eksport do Mediów Społecznościowych

Eksport do Mediów Społecznościowych

Bezpieczeństwo wykonania obrazowania metodą rezonansu magnetycznego u pacjentów z implantami sercowo-naczyniowymi

Krzysztof Piotr Karwat1, Jarosław Zalewski1
Kardiol Inwazyjna 2018;13(4):4-7.

Streszczenie

Pacjenci z implantami sercowo-naczyniowymi są często dyskwalifikowani od badania metodą rezonansu magnetycznego. Celem niniejszego dokumentu jest przedstawienie pacjentom i lekarzom obecnego stanu wiedzy na temat bezpieczeństwa rezonansu magnetycznego w tej grupie pacjentów. W badaniach producentów i niezależnych badaczy wykazano, że większość implantów sercowo-naczyniowych jest bezpieczna lub warunkowo bezpieczna w polu magnetycznym o indukcji ≤3.0 T oraz prawie wszystkie implanty sercowo-naczyniowe są bezpieczne w polu magnetycznym o indukcji ≤1.5 T.

Artykuł dostępny w formacie PDF

Pokaż PDF Pobierz plik PDF

Referencje

  1. Sommer T, Maintz D, Schmiedel A, et al. [High field MR imaging: magnetic field interactions of aneurysm clips, coronary artery stents and iliac artery stents with a 3.0 Tesla MR system]. Rofo. 2004; 176(5): 731–738.
  2. Soulen RL, Budinger TF, Higgins CB. Magnetic resonance imaging of prosthetic heart valves. Radiology. 1985; 154(3): 705–707.
  3. Edwards MB, Draper ERC, Hand JW, et al. Mechanical testing of human cardiac tissue: some implications for MRI safety. J Cardiovasc Magn Reson. 2005; 7(5): 835–840.
  4. Edwards MB, Taylor KM, Shellock FG. Prosthetic heart valves: evaluation of magnetic field interactions, heating, and artifacts at 1.5 T. J Magn Reson Imaging. 2000; 12(2): 363–369.
  5. Baikoussis NG, Apostolakis E, Papakonstantinou NA, et al. Safety of magnetic resonance imaging in patients with implanted cardiac prostheses and metallic cardiovascular electronic devices. Ann Thorac Surg. 2011; 91(6): 2006–2011.
  6. Pruefer D, Kalden P, Schreiber W, et al. In vitro investigation of prosthetic heart valves in magnetic resonance imaging: evaluation of potential hazards. J Heart Valve Dis. 2001; 10(3): 410–414.
  7. Bock M, Mohrs OK, Voigtlaender T, et al. [MRI safety aspects and artifacts of atrial septal defect and patent foramen ovale occluders at 1.5 tesla: a phantom study]. Rofo. 2006; 178(3): 272–277.
  8. Shellock FG, Morisoli SM. Ex vivo evaluation of ferromagnetism and artifacts of cardiac occluders exposed to a 1.5-T MR system. J Magn Reson Imaging. 1994; 4(2): 213–215.
  9. Saeedi M, Thomas A, Shellock FG. Evaluation of MRI issues at 3-Tesla for a transcatheter aortic valve replacement (TAVR) bioprosthesis. Magn Reson Imaging. 2015; 33(4): 497–501.
  10. Krumm P, Zuern CS, Wurster TH, et al. Cardiac magnetic resonance imaging in patients undergoing percutaneous mitral valve repair with the MitraClip system. Clin Res Cardiol. 2014; 103(5): 397–404.
  11. Strona internetowa Institute for Magnetic Resonance Safety, Education, and Research. http://www.mrisafety.com/ (13.08.2018).
  12. Santoro D, Winter L, Müller A, et al. Detailing radio frequency heating induced by coronary stents: a 7.0 Tesla magnetic resonance study. PLoS One. 2012; 7(11): e49963.
  13. ASTM F2503-13, Standard Practice for Marking Medical Devices and Other Items for Safety in the Magnetic Resonance Environment. American Society for Testing and Materials (ASTM) International, ASTM International, West Conshohocken, PA, 2013. www.astm.org (13.08.2018).
  14. Levine GN, Gomes AS, Arai AE, et al. American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, American Heart Association Council on Clinical Cardiology, American Heart Association Council on Cardiovascular Radiology and Intervention. Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic Resonance. Circulation. 2007; 116(24): 2878–2891.
  15. Hundley WG, Bluemke DA, Finn JP, et al. American College of Cardiology Foundation Task Force on Expert Consensus Documents. ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol. 2010; 55(23): 2614–2662.
  16. Nagel E, Hug J, Bünger S, et al. Coronary flow measurements for evaluation of patients after stent implantation. MAGMA. 1998; 6(2-3): 184–185.
  17. Porto I, Selvanayagam J, Ashar V, et al. Safety of magnetic resonance imaging one to three days after bare metal and drug-eluting stent implantation. Am J Cardiol. 2005; 96(3): 366–368.
  18. Shellock FG. Guidelines for the Management of Patients with Coronary Artery Stents Referred for MRI Procedures. http://www.mrisafety.com/SafetyInfov.asp?SafetyInfoID=352 (13.08.2018).
  19. Shellock FG. Guidelines for the Management of Patients with Heart Valve Prostheses and Annuloplasty Rings Referred for MRI Procedures. http://www.mrisafety.com/SafetyInfov.asp?SafetyInfoID=353 (13.08.2018).